Case Report: Arterial Wall Inflammation in Atherosclerotic Cardiovascular Disease is Reduced by Olamkicept (sgp130Fc)

Inflammation is a strong driver of atherosclerotic cardiovascular disease (ASCVD). There is a large unmet need for therapies that prevent or reduce excessive inflammation while avoiding systemic immunosuppression. We showed previously that selective inhibition of pro-inflammatory interleukin-6 (IL-6...

Descripción completa

Detalles Bibliográficos
Autores principales: Schulte, Dominik M., Waetzig, Georg H., Schuett, Harald, Marx, Marlies, Schulte, Berenice, Garbers, Christoph, Lokau, Juliane, Vlacil, Ann-Kathrin, Schulz, Juliane, Seoudy, Anna K., Schieffer, Bernhard, Rosenstiel, Philip, Seeger, Marcus, Laudes, Matthias, Rose-John, Stefan, Lützen, Ulf, Grote, Karsten, Schreiber, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218605/
https://www.ncbi.nlm.nih.gov/pubmed/35754497
http://dx.doi.org/10.3389/fphar.2022.758233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218605/
https://www.ncbi.nlm.nih.gov/pubmed/35754497
http://dx.doi.org/10.3389/fphar.2022.758233

Ejemplares similares